Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
69.97
-0.30 (-0.43%)
At close: Oct 10, 2025, 4:00 PM EDT
70.42
+0.45 (0.64%)
After-hours: Oct 10, 2025, 7:59 PM EDT
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
$883,115
Profits / Employee
-$250,904
Market Cap
11.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | 660 | -97 | -12.81% |
| Dec 31, 2020 | 757 | -60 | -7.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IONS News
- 3 days ago - Ionis Pharmaceuticals, Inc. (IONS) Shareholder/Analyst Call Transcript - Seeking Alpha
- 4 days ago - Ionis showcases transformational medicines and industry-leading pipeline at Innovation Day - Business Wire
- 18 days ago - Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial - Benzinga
- 19 days ago - Ionis' brain disorder drug shows promise in clinical trial - Reuters
- 19 days ago - Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease - Business Wire
- 22 days ago - TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS) - Business Wire
- 4 weeks ago - Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases - Business Wire
- 4 weeks ago - Ionis: Recent Approvals, Upcoming Catalysts To Spur Strong Upside (Rating Upgrade) - Seeking Alpha